Wednesday, November 09, 2016 3:37:06 AM
NanoLogix is pleased to announce the recent peer-reviewed research paper published in the Journal of Infectious Diseases in Obstetrics and Gynecology has been rated by AltMetric and Kudos, two services for tracking published research. In AltMetric, it was ranked as #1 out of 128 articles published in the above mentioned journal. In Kudos, the research paper was ranked in the top five percent of over 100,000 research outputs.
In addition, CEO Bret Barnhizer has been in meetings in Houston with both Drs. Sebastian and Jonathan Faro, along with investors, to plan and execute the next steps in the evolution of N-Assay studies, certifications, production, and marketing plans. The initial production has been and will be in Texas for the immediate future, during which time NanoLogix will be pursuing further plans to establish production in Ohio.
Good to know.
EI
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM